Seelos Therapeutics Inc (SEEL)
NASDAQ
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
The current SEEL market cap is 1.11M. The company's latest EPS is USD -17.4324 and P/E is -0.03.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 808k | 336k | 406k | 653k | 579k |
| Operating Income | -8.93M | -10.95M | -12.6M | -8.01M | -6.06M |
| Net Income | -13.43M | -29.5M | 10.5M | -5.45M | -2.66M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 375k | 0 | 0 | 0 | 2.2M |
| Operating Income | -29.75M | -18.76M | -61.67M | -70.92M | -40.5M |
| Net Income | -51.26M | -19.1M | -66.05M | -73.53M | -37.88M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 23.64M | 11.89M | 6.22M | 5.42M | 3.61M |
| Total Liabilities | 44.3M | 59.07M | 36.63M | 38.93M | 36.72M |
| Total Equity | -20.66M | -47.18M | -30.41M | -33.51M | -33.1M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 11.1M | 17.49M | 83.5M | 22.75M | 5.42M |
| Total Liabilities | 11.1M | 14.92M | 26.18M | 33.36M | 38.93M |
| Total Equity | -7k | 2.57M | 57.32M | -10.61M | -33.51M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -10.35M | -16.25M | -22M | -23.91M | -4.64M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 8.87M | 6.56M | 9.05M | 11.38M | 2.17M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -19.31M | -20.91M | -49M | -61.6M | -23.91M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 29.52M | 26.31M | 112.07M | -1.6M | 11.38M |
| Market Cap | 1.11M |
| Price to Earnings Ratio | -0.03 |
| Price to Sales Ratio | 0.51 |
| Price to Cash Ratio | 0.38 |
| Price to Book Ratio | -0.03 |
| Dividend Yield | - |
| Shares Outstanding | 2.17M |
| Average Volume (1 week) | 397.31k |
| Average Volume (1 Month) | 1.33M |
| 52 Week Change | -99.87% |
| 52 Week High | 398.40 |
| 52 Week Low | 0.4711 |
| Spread (Intraday) | 0.01 (2.67%) |
| Company Name | Seelos Therapeutics Inc |
| Address |
701 s carson st carson city, nevada 89701 |
| Website | https://seelostherapeutics.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
